| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |